The Column Group is a venture capital firm dedicated to creating the biotechnology companies.
Phone: 415-865-2050
1700 Owens Street
Suite 500
San Francisco, 94158
California, United States
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2018-05-18 | Accent Therapeutics | Series A | $40M | Atlas Venture, and EcoR1 Capital |
| 2018-04-24 | REVOLUTION Medicines | Series B | $56M | Casdin Capital, Nextech Invest, Schroder Adveq, and Third Rock Ventures |
| 2018-04-09 | Escient Pharmaceuticals | Series A | $40M | 5AM Ventures, and Osage University Partners |
| 2018-04-06 | Constellation Pharmaceuticals | Series D | $100M | Casdin Capital, Cormorant Asset Management, Deerfield Management, Fidelity Investments, Hillhouse Capital Management, NS Investment, OrbiMed Advisors, Sirona Capital, SR One, Third Rock Ventures, Topspin Partners, University Of California, and Venrock |
| 2018-02-22 | Kallyope | Series B | $66M | Alexandria Venture Investments, Euclidean Capital, Illumina Ventures, Lux Capital, Polaris Partners, and Two Sigma Ventures |
